USP22 and lung carcinoma: Interestingly, migration (Fig. 6C, D) and invasion (Fig. 6E, F) assays also demonstrated that overexpression of AP2 significantly enhanced cellular migration and invasion potential in the USP22-WT H1299 and A549 cancer cells, but had little effect on migration and invasion in the USP22-KO lung cancer cells.